The School of Medicine at the European University of Cyprus (EUC) is organizing the 13th International Multidisciplinary Biomedical Conference, “Bio-Medical Science CYPRUS,” with the general theme: “School of Medicine: A Vehicle for Science and Culture,” which will take place November 6–8, 2025, on the campus of the European University of Cyprus
The three-day conference is co-organized with the Pan-Cyprian Medical Association and is held under the auspices of the President of the Republic of Cyprus, Nikos Christodoulides, the Ministry of Health, and other scientific and social health organizations. The opening ceremony will take place on Thursday, November 6, at 5:00 p.m., and the conference proceedings will continue through Saturday, November 8, 2025.
The conference will feature 80 internationally renowned speakers from leading universities and medical centers abroad. The keynote speakers at the conference will be:
- Dr. Randall Starling, cardiologist
- Dr. John Ioannidis, epidemiologist
- Dr. Constantino Hadjipanayi, neurologist/neurosurgeon
The keynote speaker will be the world-renowned Professor Dr. Valentin Fuster of Mount Sinai Hospital (New York, USA).
The conference, among other things, will feature interactive presentations in fields such as cardiology, oncology, vascular diseases, diabetology, neurology, and genetics, featuring real-life clinical cases as well as open discussions. On Saturday, November 8, a special Cardiopulmonary Resuscitation (CPR) workshop will be held by the Cyprus Cardiopulmonary Resuscitation Association.
Participants will receive certification for 18 Continuing Medical Education (CME) credits from the Cyprus Medical Association, and 18 Continuing Professional Development (CPD) credits from the Cyprus Biological Society.
Registration is free and opens at 8:00 a.m.
The main sponsors of the event are Energon, PMI Scientific, the Deputy Ministry of Culture, and Pfizer, with support from Ophthalmos, Papaellinas, Novartis, Medochemie, Georgiades & Associates, Costas Christodoulou Ltd, Health Care, Deloitte, Proton Medical, Delorbis, Sobi Innoprol, AstraZeneca, Alector, and Affectory.
The 13th International Multidisciplinary Bio-Medical Conference of the European University of Cyprus reaffirms, for yet another year, the university’s role as a hub of scientific and cultural development in the southeastern Mediterranean, strengthening Cyprus’s presence on the global map of medical education and research.
The medical conferences of the European University of Cyprus are a hallmark of excellence in the Cypriot and international scientific community, featuring distinguished international speakers from world-renowned institutions abroad. The multidisciplinary scientific conference on Biomedical Sciences has established itself as a high-level, annual international gathering. This year, scientists from the U.S., Sweden, Switzerland, Finland, the United Kingdom, Greece, Poland, Romania, Lebanon, and other countries have registered to participate. For the past five years, the conference has been featured in the world-renowned scientific journal *Cell Death & Disease*, published by Nature “Cell Death & Disease,” affirming the high standard of medical research conducted in Cyprus.
The main sponsors of the event are Energon, PMI Scientific, the Deputy Ministry of Culture, and Pfizer, with support from the companies Ophthalmos, Papaellinas, Novartis, Medochemie, Georgiades & Associates, Costas Christodoulou Ltd, Health Care, Deloitte, Proton Medical, Delorbis, Sobi Innoprol, AstraZeneca, Alector, and Affectory.
